645 related articles for article (PubMed ID: 11483516)
1. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
2. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
3. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
Kaiser M; Haag J; Söder S; Bau B; Aigner T
Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
[TBL] [Abstract][Full Text] [Related]
6. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
[TBL] [Abstract][Full Text] [Related]
7. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.
Ishida W; Hamamoto T; Kusanagi K; Yagi K; Kawabata M; Takehara K; Sampath TK; Kato M; Miyazono K
J Biol Chem; 2000 Mar; 275(9):6075-9. PubMed ID: 10692396
[TBL] [Abstract][Full Text] [Related]
8. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
9. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.
Fujii M; Takeda K; Imamura T; Aoki H; Sampath TK; Enomoto S; Kawabata M; Kato M; Ichijo H; Miyazono K
Mol Biol Cell; 1999 Nov; 10(11):3801-13. PubMed ID: 10564272
[TBL] [Abstract][Full Text] [Related]
10. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
13. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
14. [The role of Smads and related transcription factors in the signal transduction of bone morphogenetic protein inducing bone formation].
Xu XL; Dai KR; Tang TT
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Sep; 17(5):359-62. PubMed ID: 14551929
[TBL] [Abstract][Full Text] [Related]
15. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
16. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
[TBL] [Abstract][Full Text] [Related]
17. Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins.
Monteiro RM; de Sousa Lopes SM; Korchynskyi O; ten Dijke P; Mummery CL
J Cell Sci; 2004 Sep; 117(Pt 20):4653-63. PubMed ID: 15331632
[TBL] [Abstract][Full Text] [Related]
18. CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter.
Ionescu AM; Drissi H; Schwarz EM; Kato M; Puzas JE; McCance DJ; Rosier RN; Zuscik MJ; O'Keefe RJ
J Cell Physiol; 2004 Mar; 198(3):428-40. PubMed ID: 14755548
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein signaling in articular chondrocyte differentiation.
Nishihara A; Fujii M; Sampath TK; Miyazono K; Reddi AH
Biochem Biophys Res Commun; 2003 Feb; 301(2):617-22. PubMed ID: 12565908
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling by Smad proteins.
Miyazono K
Cytokine Growth Factor Rev; 2000; 11(1-2):15-22. PubMed ID: 10708949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
